Last reviewed · How we verify
Age related macular degeneration
Approved treatments
- Lucentis · Santen Inc.
- Xanthophyll
- BYOOVIZ · SAMSUNG BIOEPIS CO LTD
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Age related macular degeneration patent landscape — cliff calendar, originator estates, attackable patents
- Age related macular degeneration treatment landscape brief
- Age related macular degeneration treatment updates RSS
Frequently asked questions about Age related macular degeneration
What drugs treat Age related macular degeneration?
Tracked treatments include Lucentis, Xanthophyll, BYOOVIZ.
What is the treatment for Age related macular degeneration?
Standard treatment for Age related macular degeneration includes Lucentis, Xanthophyll, BYOOVIZ. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Age related macular degeneration patent cliff · Age related macular degeneration CI report
- Treatment: Lucentis · Santen Inc.
- Treatment: Xanthophyll
- Treatment: BYOOVIZ · SAMSUNG BIOEPIS CO LTD
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing